Dallas, TXNCT07612176Now EnrollingIRB Ready

Locally Advanced (Unresectable) or Metastatic Solid Tumors Clinical Trial in Dallas, TX

Access cutting-edge locally advanced (unresectable) or metastatic solid tumors treatment through this clinical trial at a research site in Dallas. Study-provided care at no cost to qualified participants.

Sponsored by NEOK Bio, Inc.

Quick Self-Assessment

See if you qualify for this Dallas location

Preparing your pre-screening questions…

Expert Care in Dallas

Access locally advanced (unresectable) or metastatic solid tumors specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related locally advanced (unresectable) or metastatic solid tumors treatment provided free

Apply for This Dallas Location

Check if you qualify for this locally advanced (unresectable) or metastatic solid tumors clinical trial in Dallas, TX

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Dallas

    Convenient for TX residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Dallas site if eligible
  4. 4Begin participation

About This Locally Advanced (Unresectable) or Metastatic Solid Tumors Study in Dallas

This is a first in human (FIH), Phase 1, dose escalation and expansion study in select solid tumors. This study includes 2 parts: a Dose Escalation and Backfill portion (Part A) and a Dose Expansion portion (Part B).

Sponsor: NEOK Bio, Inc.

Who Can Participate

Inclusion Criteria

Participants must have locally advanced or metastatic disease in a select tumor type, for which no standard therapy is available.
Participants must have at least 1 measurable target lesion based on RECIST v1.1.
Participants must have Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1.
Participants must have adequate hematologic, hepatic, and renal function.
Participants should have available archived tumor tissue from their most recent biopsy. Key

Exclusion Criteria

Participant's most recent systemic anti-cancer treatment was an ADC with a topoisomerase 1-inhibitor payload component.
Participants with known symptomatic central nervous system (CNS) metastases or any evidence of leptomeningeal disease or evidence of unstable CNS metastases, even if asymptomatic.
Participants with a known history of interstitial lung disease (ILD) requiring steroid treatment, or for whom suspected ILD cannot be ruled out by imaging at screening.
Participants with clinically severe pulmonary compromise due to intercurrent pulmonary illness and/or pulmonary disorder requiring supplemental oxygen or any prior pneumonectomy.
Participants with a QT interval corrected for heart rate using Fridericia's formula (QTcF) ≥ 470 msec.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Dallas?

Yes, this clinical trial (NCT07612176) has an active research site in Dallas, TX that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Locally Advanced (Unresectable) or Metastatic Solid Tumors Treatment Options in Dallas, TX

If you're searching for locally advanced (unresectable) or metastatic solid tumors treatment options in Dallas, TX, this clinical trial (NCT07612176) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Dallas research site is actively enrolling participants for this clinical trial. You'll receive care from experienced locally advanced (unresectable) or metastatic solid tumors specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all locally advanced (unresectable) or metastatic solid tumors clinical trials near you to find additional studies recruiting in your area.

More Leukemia Trials in Dallas, TX

See all leukemia clinical trials recruiting in Dallas — not just this study.

Browse Leukemia Trials in Dallas →

Browse More Trials by Condition

Leukemia TrialsAdvanced Solid Tumors TrialsAlzheimers Disease TrialsEssential Tremor TrialsAnkylosing Spondylitis TrialsAtopic Dermatitis TrialsErectile Dysfunction TrialsInterstitial Cystitis TrialsAll Conditions →

Ready to Join in Dallas?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Dallas, TX